Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection-Reference-Cited by-同舟云学术

Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection

Published:2018-02-16 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Wang Gary P.,Terrault Norah,Reeves Jacqueline D.,Liu Lin,Li Eric,Zhao Lisa,Lim Joseph K.,Morelli Giuseppe,Kuo Alexander,Levitsky Josh,Sherman Kenneth E.,Frazier Lynn M.,Ramani Ananthakrishnan,Peter Joy,Akuskevich Lucy,Fried Michael W.,Nelson David R.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-21303-2.pdf

Reference35 articles.

1. Polaris Observatory, H. C. V. et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol. Hepatol. 2, 161–176 (2017).

2. WHO. Global Hepatitis Report 2017 (2017).

3. Alter, M. J. et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341, 556–562 (1999).

4. Ghany, M. G., Strader, D. B., Thomas, D. L. & Seeff, L. B. & American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49, 1335–1374 (2009).

5. Davis, G. L., Alter, M. J., El-Serag, H., Poynard, T. & Jennings, L. W. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138, e1–6 (2010). 513-21, 521.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. Analysis of resistance-associated substitutions in hepatitis C virus sequences from Kyrgyzstan;Problems of Virology;2023-07-06

3. Prevalence and molecular genetic characteristics of parenteral hepatitis B, C and D viruses in HIV positive persons in the Novosibirsk region;Problems of Virology;2022-11-19

4. Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir;Journal of Hepatology;2021-10

5. Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens;Open Forum Infectious Diseases;2021-09-30